Liyun Zhao

SPARC in hematologic malignancies and novel technique for hematological disease with its abnormal expression.

Tao Jiang, Zhongyuan Han, Chi Liu, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

HDAC/JAK dual target inhibitors of cancer-related targets: The success of nonclearable linked pharmacophore mode.

Rongsheng Tong, Jianyou Shi, Zhongliang Jiang, 2022, Bioorganic chemistry.

Recent advances of dual FGFR inhibitors as a novel therapy for cancer.

Qi Liang, Yonghe Hu, Jianyou Shi, 2021, European journal of medicinal chemistry.

A small molecule inhibitor targeting SHP2 mutations for the lung carcinoma

Jianyou Shi, Jinhao Zeng, Q. Nian, 2021 .

A review on the treatment of multiple myeloma with small molecular agents in the past five years.

Jianyou Shi, Xin Liu, Jinqiu Li, 2021, European journal of medicinal chemistry.

Recent research and development of DYRK1A inhibitors

Rongsheng Tong, Lan Bai, Jianyou Shi, 2021, Chinese Chemical Letters.

Historical perspectives and recent advances in small molecule ligands of selective/biased/multi-targeted μ/δ/κ opioid receptor (2019-2022).

Liyun Zhao, Ye He, Qian Su, 2023, Bioorganic chemistry.

Emerging phosphodiesterase inhibitors for treatment of neurodegenerative diseases

Liyun Zhao, Yu Xiang, Jianyou Shi, 2024, Medicinal research reviews.